666 related articles for article (PubMed ID: 28346597)
21. Cytomegalovirus viremia, mortality, and end-organ disease among patients with AIDS receiving potent antiretroviral therapies.
Wohl DA; Zeng D; Stewart P; Glomb N; Alcorn T; Jones S; Handy J; Fiscus S; Weinberg A; Gowda D; van der Horst C
J Acquir Immune Defic Syndr; 2005 Apr; 38(5):538-44. PubMed ID: 15793363
[TBL] [Abstract][Full Text] [Related]
22. Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy.
Mugavero MJ; Napravnik S; Cole SR; Eron JJ; Lau B; Crane HM; Kitahata MM; Willig JH; Moore RD; Deeks SG; Saag MS;
Clin Infect Dis; 2011 Nov; 53(9):927-35. PubMed ID: 21890751
[TBL] [Abstract][Full Text] [Related]
23. Initial suboptimal CD4 reconstitution with antiretroviral therapy despite full viral suppression in a cohort of HIV-infected patients in Senegal.
Batista G; Buvé A; Ngom Gueye NF; Manga NM; Diop MN; Ndiaye K; Thiam A; Ly F; Diallo A; Ndour CT; Seydi M
Med Mal Infect; 2015 Jun; 45(6):199-206. PubMed ID: 25907261
[TBL] [Abstract][Full Text] [Related]
24. AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'Ivoire.
Anglaret X; Minga A; Gabillard D; Ouassa T; Messou E; Morris B; Traore M; Coulibaly A; Freedberg KA; Lewden C; Ménan H; Abo Y; Dakoury-Dogbo N; Toure S; Seyler C;
Clin Infect Dis; 2012 Mar; 54(5):714-23. PubMed ID: 22173233
[TBL] [Abstract][Full Text] [Related]
25. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
[TBL] [Abstract][Full Text] [Related]
26. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
Moore RD; Keruly JC
Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
[TBL] [Abstract][Full Text] [Related]
27. Brief Report: AIDS-Defining Events and Deaths in HIV-Infected Children and Adolescents on Antiretrovirals: A 14-Year Study in Thailand.
Traisathit P; Delory T; Ngo-Giang-Huong N; Somsamai R; Techakunakorn P; Theansavettrakul S; Kanjanavanit S; Mekmullica J; Ngampiyaskul C; Na-Rajsima S; Lallemant M; Cressey TR; Jourdain G; Collins IJ; Le Coeur S
J Acquir Immune Defic Syndr; 2018 Jan; 77(1):17-22. PubMed ID: 29040162
[TBL] [Abstract][Full Text] [Related]
28. Ethnicity and discordance in plasma HIV-1 RNA viral load and CD4+ lymphocyte count in a cohort of HIV-1-infected individuals.
Smith PR; Sarner L; Murphy M; James B; Thomas JM; Skinner CJ; Aitken C
J Clin Virol; 2003 Jan; 26(1):101-7. PubMed ID: 12589840
[TBL] [Abstract][Full Text] [Related]
29. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
[TBL] [Abstract][Full Text] [Related]
30. Association Between CD4
Islam M; Ramesh N; Kolman S; Koshy S; Frank M; Salomon N; Miller A; Harris M
Lung; 2017 Oct; 195(5):635-642. PubMed ID: 28647827
[TBL] [Abstract][Full Text] [Related]
31. Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009.
Blair JM; Fagan JL; Frazier EL; Do A; Bradley H; Valverde EE; McNaghten A; Beer L; Zhang S; Huang P; Mattson CL; Freedman MS; Johnson CH; Sanders CC; Spruit-McGoff KE; Heffelfinger JD; Skarbinski J;
MMWR Suppl; 2014 Jun; 63(5):1-22. PubMed ID: 24941443
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of surrogate markers and clinical outcomes in two-year follow-up of eighty-six human immunodeficiency virus-infected pediatric patients.
Valentine ME; Jackson CR; Vavro C; Wilfert CM; McClernon D; St Clair M; Katz SL; McKinney RE
Pediatr Infect Dis J; 1998 Jan; 17(1):18-23. PubMed ID: 9469389
[TBL] [Abstract][Full Text] [Related]
33. Mortality in HIV-infected women, heterosexual men, and men who have sex with men in Rio de Janeiro, Brazil: an observational cohort study.
Coelho L; Grinsztejn B; Castilho JL; De Boni R; Quintana MS; Campos DP; Ribeiro SR; Pacheco AG; Veloso VG; Luz PM
Lancet HIV; 2016 Oct; 3(10):e490-8. PubMed ID: 27658875
[TBL] [Abstract][Full Text] [Related]
34. No differences in clinical outcomes with the addition of viral load testing to CD4 cell count monitoring among HIV infected participants receiving ART in rural Uganda: Long-term results from the Home Based AIDS Care Project.
Okoboi S; Ekwaru PJ; Campbell JD; Egessa A; King R; Bakanda C; Muramuzi E; Kaharuza F; Malamba S; Moore DM
BMC Public Health; 2016 Feb; 16():101. PubMed ID: 26830678
[TBL] [Abstract][Full Text] [Related]
35. Patterns of detectable viral load in a cohort of HIV-positive adolescents on antiretroviral therapy in South Africa.
Sher R; Dlamini S; Muloiwa R
J Int AIDS Soc; 2020 Mar; 23(3):e25474. PubMed ID: 32180367
[TBL] [Abstract][Full Text] [Related]
36. Predicting Viral Failure in Human Immunodeficiency Virus Perinatally Infected Youth With Persistent Low-Level Viremia on Highly Active Antiretroviral Therapy.
Pereira R; Ludwig DA; Mathew S; Flores C; Dominguez S; Gonzalez I; Rivera-Hernandez D; Scott GB; Mitchell CD
J Pediatric Infect Dis Soc; 2019 Sep; 8(4):303-309. PubMed ID: 29788421
[TBL] [Abstract][Full Text] [Related]
37. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
[TBL] [Abstract][Full Text] [Related]
38. Effect of early syphilis infection on plasma viral load and CD4 cell count in human immunodeficiency virus-infected men: results from the FHDH-ANRS CO4 cohort.
Jarzebowski W; Caumes E; Dupin N; Farhi D; Lascaux AS; Piketty C; de Truchis P; Bouldouyre MA; Derradji O; Pacanowski J; Costagliola D; Grabar S;
Arch Intern Med; 2012 Sep; 172(16):1237-43. PubMed ID: 22826097
[TBL] [Abstract][Full Text] [Related]
39. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
Panel de expertos de GESIDA y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
[TBL] [Abstract][Full Text] [Related]
40. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
